BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27485113)

  • 1. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
    Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
    Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
    Martínez-Aranda A; Hernández V; Guney E; Muixí L; Foj R; Baixeras N; Cuadras D; Moreno V; Urruticoechea A; Gil M; Oliva B; Moreno F; González-Suarez E; Vidal N; Andreu X; Seguí MA; Ballester R; Castella E; Sierra A
    Oncotarget; 2015 Dec; 6(42):44254-73. PubMed ID: 26497551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glycogene-based prognostic signature and validation of B3GNT7 as a potential biomarker and therapeutic target in breast cancer.
    Wang X; Wang Y; Chen X; He Y; Zhou X; Jiao S; Zhu Z; Wu C; Bao J
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):16957-16969. PubMed ID: 37740763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years.
    Bastos EP; Brentani H; Pasini FS; Silva AR; Torres CH; Puga RD; Ribeiro Olivieri EH; Piovezani AR; Pereira CA; Machado-Lima A; Carraro DM; Brentani MM
    PLoS One; 2014; 9(7):e101656. PubMed ID: 25006670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.
    Cava C; Bertoli G; Ripamonti M; Mauri G; Zoppis I; Della Rosa PA; Gilardi MC; Castiglioni I
    PLoS One; 2014; 9(5):e97681. PubMed ID: 24866763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
    Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
    Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.
    Bii VM; Rae DT; Trobridge GD
    Oncotarget; 2015 Nov; 6(37):39507-20. PubMed ID: 26506596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
    Li X; Rouchka EC; Brock GN; Yan J; O'Toole TE; Tieri DA; Cooper NGF
    PLoS One; 2018; 13(8):e0201813. PubMed ID: 30089167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of IDH1 gene expression error in breast tumor biopsy in patients with invasive ductal carcinoma.
    Rostami B; Kahrizi S; Ghorbani Yekta B; Ghadyani R; Keramatinia A; Hoseini SJ; Karima S; Nikzamir AR; Mansouri N; Chen M; Movafagh A
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):242-247. PubMed ID: 38678597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.
    Rakha EA; Soria D; Green AR; Lemetre C; Powe DG; Nolan CC; Garibaldi JM; Ball G; Ellis IO
    Br J Cancer; 2014 Apr; 110(7):1688-97. PubMed ID: 24619074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histo-epidemiological profile of breast cancers among women in the Central African Republic: about 174 cases.
    Balekouzou A; Yin P; Bekolo CE; Pamatika CM; Djeintote M; Nambei SW; Ba-Mpoutou B; Mandjiza DR; Shu C; Yin M; Qing T; Koffi B
    BMC Cancer; 2018 Apr; 18(1):387. PubMed ID: 29621999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis.
    Nimbalkar VP; Snijesh VP; Rajarajan S; Alexander A; Kaluve R; Ramesh R; Srinath BS; Prabhu JS
    Breast Cancer Res Treat; 2023 Jul; 200(1):139-149. PubMed ID: 37160509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid metabolites in rapidly proliferating breast cancer.
    O'Flaherty JT; Wooten RE; Samuel MP; Thomas MJ; Levine EA; Case LD; Akman SA; Edwards IJ
    PLoS One; 2013; 8(5):e63076. PubMed ID: 23658799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients.
    Pereira-Veiga T; Bravo S; Gómez-Tato A; Yáñez-Gómez C; Abuín C; Varela V; Cueva J; Palacios P; Dávila-Ibáñez AB; Piñeiro R; Vilar A; Chantada-Vázquez MDP; López-López R; Costa C
    Mol Cell Proteomics; 2022 Dec; 21(12):100435. PubMed ID: 36519745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3'UTR signature defines a highly metastatic subgroup of triple-negative breast cancer.
    Wang L; Hu X; Wang P; Shao ZM
    Oncotarget; 2016 Sep; 7(37):59834-59844. PubMed ID: 27494850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBXN1 promotes liver tumorigenesis by regulating mitochondrial homeostasis.
    Jiao K; Xu G; Liu Y; Yang Z; Xiang L; Chen Z; Xu C; Zuo Y; Wu Z; Zheng N; Xu W; Zhang L; Liu Y
    J Transl Med; 2024 May; 22(1):485. PubMed ID: 38773518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells.
    Morelli C; Chiodo C; Nocito MC; Cormace A; Catalano S; Sisci D; Sirianni R; Casaburi I; Andò S; Lanzino M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas.
    Cerqueira OLD; Botelho MCS; Fiore APZP; Osório CABT; Tomasin R; Morais MCC; López RVM; Cardoso EC; Vilella-Arias SA; Reis EM; Bruni-Cardoso A
    Neoplasia; 2022 Aug; 30():100803. PubMed ID: 35526305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma.
    Xie C; Xiang W; Shen H; Shen J
    J Orthop Surg Res; 2021 Dec; 16(1):713. PubMed ID: 34876170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.